MYDRIACYL MYDOLATE MYDRIATICUM TROPIC MYDROPIC MYDROMIDE OPHTH-DILATE TROPICAFIN TROPICAFIN MYDREX

Dose: 0.5 to 1 %
Single Dose: 0.75 (0.75)
Frequency: As recommended.
Route: Ophthalmic
Instructions: As Required.To be given as drops.

Dose: 0.5 to 1 mg
Single Dose: 0.75 (0.75)
Frequency: As recommended.
Route: Opthalmic
Instructions: As Required

belongs to Tertiary Amine. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Opthalmic Agent, Mydriatic pharmacological group.The Molecular Weight of Tropicamide is 284.40.

Tropicamide is contraindicated in conditions like Glucoma.

The severe or irreversible adverse effects of Tropicamide, which give rise to further complications include Increased IOP (intraocular pressure).The symptomatic adverse reactions produced by Tropicamide are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Blurred vision, Dermatitis, Eczematous rash, Xerostomia.

Tropicamide is primarily indicated in conditions like Duodenal ulcer associated with h. Pylori, Iridocyclitis, Iritis, Keratosis, and can also be given in adjunctive therapy as an alternative drug of choice in Surgery.

No data regarding the interactions of Tropicamide was found.

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Eye Drops Store Below 40°C. Do not Freeze.

Tropicamide should be used with caution in patients with glaucoma, any illness or allergy. This medication should be used cautiously in the elderly person. It should be used with caution during pregnancy or lactation.